1.Hossein-nezhad, A & Holick, MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88, 720–755.
2.Leung, RY, Cheung, BM, Nguyen, U-S et al. (2017) Optimal vitamin D status and its relationship with bone and mineral metabolism in Hong Kong Chinese. Bone 97, 293–298.
3.Holick, MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 6 Suppl., 1678S–1688S.
4.Forman, JP, Giovannucci, E, Holmes, MD et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 1063–1069.
5.Forouhi, NG, Luan, J, Cooper, A et al. (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57, 2619–2625.
6.Judd, SE, Morgan, CJ, Panwar, B et al. (2016) Vitamin D deficiency and incident stroke risk in community-living black and white adults. Int J Stroke 11, 93–102.
7.Afzal, S, Brøndum-Jacobsen, P, Bojesen, SE et al. (2014) Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2, 298–306.
8.Norman, AW, Frankel, J, Heldt, AM et al. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209, 823–825.
9.Cade, C & Norman, AW (1986) Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 119, 84–90.
10.Cade, C & Norman, AW (1987) Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120, 1490–1497.
11.Chiu, KC, Chu, A, VLW, Go et al. (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79, 820–825.
12.Kramer, CK, Swaminathan, B, Hanley, AJ et al. (2014) Prospective associations of vitamin D status with β-cell function, insulin sensitivity, and glycemia: the impact of parathyroid hormone status. Diabetes 63, 3868–3879.
13.Pittas, AG, Dawson-Hughes, B, Li, T et al. (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650–656.
14.Knekt, P, Laaksonen, M, Mattila, C et al. (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19, 666–671.
15.Grimnes, G, Emaus, N, Joakimsen, R et al. (2010) Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 27, 1107–1115.
16.Yiu, Y-F, Chan, Y-H, Yiu, K-H et al. (2011) Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 96, E830–E835.
17.Yiu, Y-F, Yiu, K-H, Siu, C-W et al. (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227, 140–146.
18.Sing, C, Cheng, V, Ho, D et al. (2016) Serum calcium and incident diabetes: an observational study and meta-analysis. Osteoporos Int 27, 1747–1754.
19.Rooney, MR, Pankow, JS, Sibley, SD et al. (2016) Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr 104, 1023–1029.
20.Cheung, C-L, Sham, PC, Chan, V et al. (2008) Identification of LTBP2 on chromosome 14q as a novel candidate gene for bone mineral density variation and fracture risk association. J Clin Endocrinol Metab 93, 4448–4455.
21.Cheung, C-L, Tan, KC & Kung, AW (2017) Cohort profile: the Hong Kong Osteoporosis Study and the follow-up study. Int J Epidemiol 47, 397f–398f.
22.So, J, Tang, W, Leung, WK et al. (2017) Cancer risk in 2621 Chinese patients with inflammatory bowel disease: a population-based cohort study. Inflamm Bowel Dis 23, 2061–2068.
23.Chan, EW, Lau, WC, Leung, WK et al. (2015) Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study. Gastroenterology 149, 586–595.e3.
24.Stepman, HC, Vanderroost, A, Van Uytfanghe, K et al. (2011) Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope dilution–liquid chromatography–tandem mass spectrometry. Clin Chem 57, 441–448.
25.Mineva, EM, Schleicher, RL, Chaudhary-Webb, M et al. (2015) A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 using isotope-dilution liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem 407, 5615–5624.
26.Leslie, WD, Rubin, MR, Schwartz, AV et al. (2012) Type 2 diabetes and bone. J Bone Miner Res 27, 2231–2237.
27.Bischoff-Ferrari, HA, Giovannucci, E, Willett, WC et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 18–28.
28.Boucher, B, Mannan, N, Noonan, K et al. (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38, 1239–1245.
29.Kayaniyil, S, Retnakaran, R, Harris, SB et al. (2011) Prospective associations of vitamin D with β-cell function and glycemia. Diabetes 60, 2947–2953.
30.Maestro, B, Campión, J, Dávila, N et al. (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47, 383–391.
31.Fadda, GZ, Akmal, M, Lipson, L et al. (1990) Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. Am J Physiol 258, E975–E984.
32.Soric, MM, Renner, ET & Smith, SR (2012) Effect of daily vitamin D supplementation on HbA1c in patients with uncontrolled type 2 diabetes mellitus: a pilot study. J Diabetes 4, 104–105.
33.Krul-Poel, YH, Westra, S, ten Boekel, E et al. (2015) Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY trial): a randomized placebo-controlled trial. Diabetes Care 38, 1420–1426.
34.Lucato, P, Solmi, M, Maggi, S et al. (2017) Low vitamin D levels increase the risk of type 2 diabetes in older adults: a systematic review and meta-analysis. Maturitas 100, 8–15.
35.Afzal, S, Bojesen, SE & Nordestgaard, BG (2013) Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 59, 381–391.
36.Kirii, K, Mizoue, T, Iso, H et al. (2009) Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 52, 2542–2550.
37.Napoli, N, Schafer, AL, Lui, L-Y et al. (2016) Serum 25-hydroxyvitamin D level and incident type 2 diabetes in older men, the Osteoporotic Fractures in Men (MrOS) study. Bone 90, 181–184.
38.Schafer, A, Napoli, N, Lui, L et al. (2014) Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women. Diabet Med 31, 564–569.
39.Robinson, JG, Manson, JE, Larson, J et al. (2011) Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care 34, 628–634.
40.Seida, JC, Mitri, J, Colmers, IN et al. (2014) Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 99, 3551.
41.Moreira-Lucas, TS, Duncan, AM, Rabasa-Lhoret, R et al. (2017) Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): a double-blind, randomized, placebo-controlled clinical trial. Diabetes Obes Metab 19, 133–141.
42.Thomas, GN, Scragg, R, Jiang, CQ et al. (2012) Hyperglycaemia and vitamin D: a systematic overview. Curr Diabetes Rev 8, 18–31.
43.Liu, S, Song, Y, Ford, ES et al. (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 28, 2926–2932.
44.Liu, E, Meigs, JB, Pittas, AG et al. (2010) Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 91, 1627–1633.
45.Schöttker, B, Herder, C, Rothenbacher, D et al. (2013) Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol 28, 267–275.
46.Pittas, AG, Sun, Q, Manson, JE et al. (2010) Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33, 2021–2023.
47.Thorand, B, Zierer, A, Huth, C et al. (2011) Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation. Diabetes Care 34, 2320–2322.
48.Krul-Poel, YH, Ter Wee, MM, Lips, P et al. (2016) Management of endocrine disease: the effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Eur J Endocrinol 176, R1–R14.
49.Jorde, R, Sollid, ST, Svartberg, J et al. (2016) Vitamin D 20 000 IU per week for five years does not prevent progression from prediabetes to diabetes. J Clin Endocrinol Metab 101, 1647–1655.
50.Fuleihan, GE-H, Baddoura, R, Habib, RH et al. (2016) Effect of vitamin D replacement on indexes of insulin resistance in overweight elderly individuals: a randomized controlled trial. Am J Clin Nutr 104, 315–323.
51.Heijboer, AC, Blankenstein, MA, Kema, IP et al. (2012) Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 58, 543–548.